---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-031675"
form_type: "8-K"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2026-07-02T12:55:15+00:00"
generated_at: "2026-07-02T13:00:16.964728+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# DNA X enters securities purchase agreement for $8.1M private placement of Series B Preferred Stock

## Summary
- DNA X agreed to issue 1,346,531 shares of Series B Convertible Preferred Stock at $6.00 per share to DNA Holdings Venture, Inc. for aggregate $8.1M.
- The $8.1M consists of $5.0M in cash and cancellation of $3.1M convertible promissory note issued in May 2026.
- DNA Holdings is an entity associated with board member Scott Walker and holds >5% of DNA X common stock.
- The Series B Preferred Stock is non-voting and automatically converts to common stock upon stockholder approval.
- DNA X also entered into a registration rights agreement for resale of common shares issuable upon conversion.

## SEC filing metadata
- accession: 0001493152-26-031675
- form_type: 8-K
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2026-07-02T12:55:15+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 5.03, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000149315226031675/0001493152-26-031675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000149315226031675/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-031675
- JSON: https://secwatch.observer/filing/0001493152-26-031675.json
- Plain text: https://secwatch.observer/filing/0001493152-26-031675.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.